Clinical Trials Insight: 700026207
Phase of Trial: Phase I
Latest Information Update: 29 Apr 2009
At a glance
- Drugs Gemcitabine; LErafAON
- Indications Pancreatic cancer
- Focus Therapeutic Use
- Sponsors NeoPharm Inc
- 29 Apr 2009 NeoPharm is developing clinical protocols for Phase I and II studies of pancreatic cancer with LE-rafAON in combination with the drug gemcitabine, according to a company media release.
- 13 May 2008 IND submission expected mid-2008.
- 20 Aug 2007 New trial record.